Literature DB >> 14531005

Preoperative detection of hepatocellular carcinoma: comparison of combined contrast-enhanced MR imaging and combined CT during arterial portography and CT hepatic arteriography.

Hyo-Sung Kwak1, Jeong-Min Lee, Chong-Soo Kim.   

Abstract

The aim of this study was to compare Gd-DTPA-enhanced dynamic MR images, superparamagnetic iron oxide (SPIO)-enhanced MR images, combined Gd-DTPA-enhanced dynamic and SPIO-enhanced MR images, vs combined CT arterial portography (CTAP) and CT hepatic arteriography (CTHA), in the detection of hepatocellular carcinoma (HCC) using receiver operating characteristic (ROC) analysis. Twenty-four patients with 38 nodular HCCs (5-60 mm, mean 23.0 mm) were retrospectively analyzed. Image reviews were conducted on a liver segment-by-segment basis. A total of 192 segments, including 36 segments with 38 HCC, were reviewed independently by three radiologists. Each radiologist read four sets of images (set 1, unenhanced and Gd-DTPA-enhanced dynamic MR images; set 2, unenhanced and SPIO-enhanced MR images; set 3, combined Gd-DTPA-enhanced dynamic and SPIO-enhanced MR images; set 4, combined CTAP and CTHA). To minimize any possible learning bias, the reviewing order was randomized and the reviewing procedure was performed in four sessions at 2-week intervals. The diagnostic accuracy (A(z) values) for HCCs of combined CTAP and CTHA, combined Gd-DTPA-enhanced dynamic and SPIO-enhanced MR images, Gd-DTPA-enhanced dynamic MR images, and SPIO-enhanced MR images for all observers were 0.934, 0.963, 0.878, and 0.869, respectively. The diagnostic accuracy of combined CTAP and CTHA and combined Gd-DTPA-enhanced dynamic and SPIO-enhanced MR images was significantly higher than Gd-DTPA-enhanced dynamic MR images or SPIO-enhanced MR images ( p<0.005). The mean specificity of combined CTAP and CTHA (93%) and combined Gd-DTPA-enhanced dynamic and SPIO-enhanced MR images (95%) was significantly higher than Gd-DTPA-enhanced dynamic MR images (87%) or SPIO-enhanced MR images (88%; p<0.05). Combined Gd-DTPA-enhanced dynamic and SPIO-enhanced MR images may obviate the need for more invasive combined CTAP and CTHA for the preoperative evaluation of patients with HCC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14531005     DOI: 10.1007/s00330-003-2070-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  33 in total

1.  Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.

Authors:  Y Tang; Y Yamashita; A Arakawa; T Namimoto; K Mitsuzaki; Y Abe; K Katahira; M Takahashi
Journal:  AJR Am J Roentgenol       Date:  1999-06       Impact factor: 3.959

2.  Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography, and MR imaging.

Authors:  J P Heiken; P J Weyman; J K Lee; D M Balfe; D Picus; E M Brunt; M W Flye
Journal:  Radiology       Date:  1989-04       Impact factor: 11.105

3.  Detection of hepatocellular carcinoma in patients with cirrhosis: MR imaging versus angiographically assisted helical CT.

Authors:  M Kanematsu; H Hoshi; T Murakami; Y Inaba; T Kim; T Yamada; M Kato; R Yokoyama; H Nakamura
Journal:  AJR Am J Roentgenol       Date:  1997-12       Impact factor: 3.959

4.  Signal changes in liver and spleen after Endorem administration in patients with and without liver cirrhosis.

Authors:  W Hundt; R Petsch; T Helmberger; M Reiser
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

5.  Detection and characterization of hepatic tumors: value of combined helical CT hepatic arteriography and CT during arterial portography.

Authors:  M Kanematsu; H Hoshi; T Imaeda; T Murakami; Y Inaba; R Yokoyama; H Nakamura
Journal:  AJR Am J Roentgenol       Date:  1997-05       Impact factor: 3.959

6.  Sensitivity in detection of hypervascular hepatocellular carcinoma by helical CT with intra-arterial injection of contrast medium, and by helical CT and MR imaging with intravenous injection of contrast medium.

Authors:  M Hori; T Murakami; H Oi; T Kim; S Takahashi; M Matsushita; K Tomoda; Y Narumi; K Kadowaki; H Nakamura
Journal:  Acta Radiol       Date:  1998-03       Impact factor: 1.990

7.  Hepatic tumors: comparison of CT during arterial portography, delayed CT, and MR imaging for preoperative evaluation.

Authors:  R C Nelson; J L Chezmar; P H Sugarbaker; M E Bernardino
Journal:  Radiology       Date:  1989-07       Impact factor: 11.105

8.  Hepatocellular carcinoma in cirrhotic livers: detection with unenhanced and iron oxide-enhanced MR imaging.

Authors:  H Yamamoto; Y Yamashita; S Yoshimatsu; Y Baba; Y Hatanaka; R Murakami; T Nishiharu; M Takahashi; Y Higashida; N Moribe
Journal:  Radiology       Date:  1995-04       Impact factor: 11.105

9.  Hypervascular hepatocellular carcinoma: can double arterial phase imaging with multidetector CT improve tumor depiction in the cirrhotic liver?

Authors:  Tomoaki Ichikawa; Takatoshi Kitamura; Hiroto Nakajima; Hironobu Sou; Tatsuaki Tsukamoto; Satoshi Ikenaga; Tsutomu Araki
Journal:  AJR Am J Roentgenol       Date:  2002-09       Impact factor: 3.959

10.  Small hepatocellular carcinoma: evaluation of portal blood flow with CT during arterial portography performed with balloon occlusion of the hepatic artery.

Authors:  S Saitoh; K Ikeda; I Koida; A Tsubota; Y Arase; K Chayama; H Kumada
Journal:  Radiology       Date:  1994-10       Impact factor: 11.105

View more
  12 in total

1.  Transcatheter arterial chemoembolization in patients with hepatocellular carcinoma and coexisting hepatic cavernous hemangioma.

Authors:  Ran-Chou Chen; Jiunn-Ming Lii; Wei-Tsung Chen; Hsing-Yang Tu; Liang-Chung Chiang
Journal:  Eur Radiol       Date:  2005-12-06       Impact factor: 5.315

2.  Detection of hepatocellular carcinoma: comparison of Gd-DTPA- and ferumoxides-enhanced MR imaging.

Authors:  G Simon; T M Link; K Wörtler; F Doebereiner; E Schulte-Frohlinde; H Daldrup-Link; M Settles; E J Rummeny
Journal:  Eur Radiol       Date:  2005-03-31       Impact factor: 5.315

3.  Comparison of gadoxetic acid-enhanced magnetic resonance imaging and contrast-enhanced computed tomography with histopathological examinations for the identification of hepatocellular carcinoma: a multicenter phase III study.

Authors:  Masakatsu Tsurusaki; Keitaro Sofue; Hiroyoshi Isoda; Masahiro Okada; Kazuhiro Kitajima; Takamichi Murakami
Journal:  J Gastroenterol       Date:  2015-07-01       Impact factor: 7.527

4.  Transarterial chemoembolization alone and in combination with other therapies: a comparative study in an animal HCC model.

Authors:  A Maataoui; J Qian; D Vossoughi; M F Khan; E Oppermann; W O Bechstein; T J Vogl
Journal:  Eur Radiol       Date:  2004-12-04       Impact factor: 5.315

5.  Detection of hepatocellular carcinoma: comparison of ferumoxides-enhanced and gadolinium-enhanced dynamic three-dimensional volume interpolated breath-hold MR imaging.

Authors:  Hyo-Sung Kwak; Jeong-Min Lee; Young-Kon Kim; Young Hwan Lee; Chong-Soo Kim
Journal:  Eur Radiol       Date:  2004-09-22       Impact factor: 5.315

Review 6.  Enhancement patterns and signal-intensity characteristics of small hepatocellular carcinoma in cirrhosis: pathologic basis and diagnostic challenges.

Authors:  Stavros C Efremidis; Prodromos Hytiroglou; Osamu Matsui
Journal:  Eur Radiol       Date:  2007-07-06       Impact factor: 5.315

7.  C-arm CT during hepatic arteriography tumour-to-liver contrast: intraindividual comparison of three different contrast media application protocols.

Authors:  Claus Koelblinger; Wolfgang Schima; Vanessa Berger-Kulemann; Florian Wolf; Christina Plank; Michael Weber; Johannes Lammer
Journal:  Eur Radiol       Date:  2012-11-09       Impact factor: 5.315

Review 8.  Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media.

Authors:  Carlo Bartolozzi; Laura Crocetti; Riccardo Lencioni; Dania Cioni; Clotilde Della Pina; Daniela Campani
Journal:  Eur Radiol       Date:  2007-02-16       Impact factor: 7.034

9.  Intra-hepatic splenosis as an unexpected cause of a focal liver lesion in a patient with hepatitis C and liver cirrhosis: a case report.

Authors:  Marianne Menth; Karin Herrmann; Alexander Haug; Bijan Raziorrouh; Reinhart Zachoval; Christina-Maria Jung; Carsten Otto
Journal:  Cases J       Date:  2009-08-19

Review 10.  Hepatocellular carcinoma: development and early detection.

Authors:  Philip Robinson
Journal:  Cancer Imaging       Date:  2008-10-04       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.